Wednesday, July 8, 2026

pharma · Hypertriglyceridemia · Type 2 Diabetes Mellitus · IONS

IONIS PHARMACEUTICALS

IONIS PHARMACEUTICALS is a pharma organization headquartered in Carlsbad, USA. It trades on NYSE under ticker IONS. Primary therapeutic focus areas include Hypertriglyceridemia, Type 2 Diabetes Mellitus, Familial Chylomi

2855 Gazelle Ct, Carlsbad, CA 92010, US HQ
1989 Founded
1,493 Employees
Public company Type
IONS · NYSE Ticker
Company details
Status
Public
HQ
2855 Gazelle Ct, Carlsbad, CA 92010, US
Founded
1989
Employees
1,493
Programs
128
Drugs
48
Patents
222
Clinical program

Ionis AGT-LRx

Phase 1 · small molecule · Healthy Volunteers

Ionis AGT-LRx for Healthy Volunteers is a Phase 1 program (small_molecule) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

← All IONIS PHARMACEUTICALS INC projects Phase 1 small molecule completed

Internal code ISIS 757456-CS1

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
IONIS PHARMACEUTICALS INC
Phase
Phase 1
Modality
small_molecule
Indication
Healthy Volunteers
Status
completed
Trials
1

Clinical trials